Medicine
Medicine News
Global Financial Crisis Fuels Need for Greater HIV and AIDS Assistance for Children
| 12/1/2008 | JOHANNESBURG, South Africa, Dec. 1 The following is a statement from Martha Newsome, director of World Vision International's Global Health and HIV & AIDS Hope Initiatives: This World AIDS Day is being commemorated against the backdrop of a debilitating global financial crisis that threatens the livelihoods of vulnerable households and... [Comments] |
| 12/1/2008 | SOUTH EASTON, Mass., Dec. 1 Pressure BioSciences, Inc. (Nasdaq: PBIO ) ("PBI" or the "Company") today announced a comprehensive restructuring program designed to significantly reduce costs, centralize core operations, and refocus the Company's business strategy in specific areas where the Company's products have found significant market acceptance. The restructuring... [Comments] |
Young Gymnasts Facing Broad Range of New Injuries
| 12/1/2008 | MRI scans show knuckle, wrist and bone damage that could develop into early osteoarthritis MONDAY, Dec. 1 (HealthDay News) -- Young gymnasts now appear to be developing injuries well beyond one common to their sport, a new study says. Injuries to gymnasts' bones -- especially... [Comments] |  |
Health Needs of Autistic Children Often Unmet
| 12/1/2008 | Expenses greater than those for kids with other special needs, report shows MONDAY, Dec. 1 (Health Day News) -- Parents of autistic children are more likely to see their sons or daughter's special health needs go unmet, a new government report shows. Data from the National Surv... [Comments] |  |
IDO2 an active enzyme to target in pancreatic cancer
| 12/1/2008 | (PHILADELPHIA) An enzyme that is overexpressed in pancreatic cancer cells may hold the key to successfully treating the disease with targeted immunotherapy, researchers from Thomas Jefferson University reported at the 2008 Annual Meeting of the Southern Surgical Association. Previous data show that a protein, indoleamine 2,3-dioxygenase (IDO), is overexpressed in pancreatic ductal adeno... [Comments] |
Experts: Targeted agricultural investments will yield high results, slash poverty in Africa
| 12/1/2008 | MAPUTO, Mozambique (1 December 2008)Concerned that the global financial crisis will lead to cuts in funding for projects in developing countries, leaders of the world's largest agricultural research group today told a conference that relatively modest, well-targeted investments could greatly boost the livelihoods of hundreds of millions of people living on less than $1 a day. Speaking... [Comments] |
Test-tube babies profitable business for the state
| 12/1/2008 | Increased financial support for IVF fertilization would be downright profitable for the state. Test-tube babies are an investment for the future, not an expense. This is shown by Anders Svensson, who studied this issue in a bachelor's thesis in economics at Lund University School of Economics and Management in Sweden. His article on the subject was recently published in Scandinavian Journa... [Comments] |
Towards improved immunotherapy
| 12/1/2008 | Amsterdam, December 1, 2008 A study (doi:10.1016/j.clim.2008.07.027) published by Elsevier this month in Clinical Immunology , the official journal of the Clinical Immunology Society (CIS), describes a new method that facilitates the induction of a specific type of immune suppressive cells, called 'regulatory T cells' for therapeutic use. These immune suppressive cells show great potential f... [Comments] |
Medicine Products
Osteomesh Bioresorbable Implant for Craniofacial Surgery
Description:Osteomesh is a bioresorbable implant used in craniofacial surgery to repair various types of fractures, like the orbital floor fracture and to fill surgical defects. It has interconnected pores which allow rapid saturation with marrow, blood and nutrients, thus providing the patients own cells with chemical signals that are required for bone growth and remodeling. The mesh is malleable and can be...Company:Osteopore InternationalDescription:AMD Now is a forum presenting interactive education on Age- related Macular Degeneration (AMD), AMD diagnosis and treatments, VEGF, aseptic technique and supportive care for patients and caregivers....
Company:ASORN
SWISSBLADE Diamond Surgical Knives
Description:SWISSBLADE disposable surgical knives single-use blades deliver a consistent, sharp, clean cut due to the low friction coefficient achieved with Ziemers proprietary coating technology. SWISSBLADE diamond surgical knives feature top-of-the-line, reusable blades with the proven superior cutting capabilities based on the diamond expertise of Ziemer Group partner Meyco (Biel, Switzerland) an...Company:ZIEMER USA, Inc.
MAXWELL Optical Wavefront Aberrometer
Description:The MAXWELL Optical Wavefront Aberrometer is an innovative diagnostic instrument with a wide range of functions that permit eye care practitioners and researchers to effectively assess all of the wavefront aberrations present in a subjects eye. This remarkable device offers the widest wavefront diagnostic range and functions on more than 99% of subjects. Beyond its superior performance in wavefro...Company:ZIEMER USA, Inc.
ConstaVac CBCII Blood Conservation System
Description:The Stryker CBCII Blood Conservation System provides a safe, simple and economic disposable system for blood reinfusion....Company:Stryker Instruments
Medicine Technology
Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful
| 12/1/2008 | INDIANAPOLIS, Dec. 1 Roche announced today that acomparative study conducted to evaluate differences in perceived pain anddiscomfort associated with blood glucose testing showed ACCU-CHEK bloodglucose monitoring systems and lancing devices were deemed least painful. Results indicated that, overall, the ACCU-CHEK Aviva and ACCU-CHEK CompactPlus blood glucose monit... [Comments] |
Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease
| 12/1/2008 | Baby Girl with Hypophosphatasia Treated With ENB-0040 at Children's Hospital, Health Sciences Centre in Winnipeg MONTREAL, Dec. 1 Enobia Pharma, an emerging Canadian biotech company focused on developing novel therapeutics for serious bone disorders, today announced that the first infant patient in its clinical program for hypophosphatasia was dosed. Enobia is investig... [Comments] |
Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity
| 12/1/2008 | St. Jude study shows the Prox1 gene is a two-way switch that, if turned off, causes lymphatic endothelial cells to be reprogrammed so that they lose their identity and become more like blood endothelial cells MEMPHIS, Tenn., Dec. 1 Scientists at St. Jude Children's Research Hospital have discovered that a certain differentiated cell type is so ready to chan... [Comments] |
Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis
| 12/1/2008 | Abstinence is still the best policy ROCHESTER, Minn., Dec. 1 A new study from Mayo Clinic finds the use of the drug therapy etanercept ineffective in treating alcoholic hepatitis, an acute inflammation of the liver caused by excessive consumption of alcohol. The results of the study are published in the December issue of Gastroenterology ( http://ww... [Comments] |
Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics
| 12/1/2008 | PLYMOUTH MEETING, Pa., Dec. 1 Genaera Corporation (Nasdaq: GENR ) today announced that dosing of subjects has begun in study MSI-1436C-102 (Study 102), the multiple ascending dose Phase 1b study of trodusquemine (MSI-1436) in overweight and obese type 2 diabetics. MSI-1436 is a novel therapeutic for the treatment of type 2 diabetes and obesity which works centrally a... [Comments] |
(Date:12/1/2008)...-- For difficult to diagnose patients,Breast-Spe...seful adjunctive,imaging tool than ultrasound for... questionable mammogram, this according to finding...diological Society of North America (RSNA).,BSGI ...ee lesions independent,of tissue density and disc...
(Date:12/1/2008)...wire/ -- Organogenesis, Inc., a leading,regenerat...pient of two,prestigious awards honoring the comp... economic impact. , Organogenesis, manufact...ear" by Pharmaceutical Manufacturing, a prominent ...or will be highlighted in the magazine,s upcoming,...
(Date:12/1/2008)...G, South Africa, Dec. 1 ... director of World Vision International,s Global H..., This World AIDS Day is being commemorated agai...l crisis that threatens the livelihoods of vulnera...erventions to protect children. , , Existin...
(Date:12/1/2008)... that is overexpressed in pancreatic cancer cells ...ase with targeted immunotherapy, researchers from ...nnual Meeting of the Southern Surgical Association...ne 2,3-dioxygenase (IDO), is overexpressed in panc...an R. Brody, Ph.D., an assistant professor in the ...
Breaking Medicine News(10 mins):Health News:Molecular Breast Imaging Performs Better Than Ultrasound in Patients With Mammographic Abnormalities 2Health News:Organogenesis Receives Two Prestigious Awards for Economic Impact and Manufacturing Excellence 2Health News:Organogenesis Receives Two Prestigious Awards for Economic Impact and Manufacturing Excellence 3Health News:Organogenesis Receives Two Prestigious Awards for Economic Impact and Manufacturing Excellence 4Health News:Global Financial Crisis Fuels Need for Greater HIV and AIDS Assistance for Children 2Health News:IDO2 an active enzyme to target in pancreatic cancer 2[0] Molecular Breast Imaging Performs Better Than Ultrasound in Patients With Mammographic Abnormalities[0] Organogenesis Receives Two Prestigious Awards for Economic Impact and Manufacturing Excellence[0] Global Financial Crisis Fuels Need for Greater HIV and AIDS Assistance for Children[0] IDO2 an active enzyme to target in pancreatic cancer
... strategy for infecting cornea cells that may also...g to a study by researchers// at the University of...dy appears in the Sept. 25 issue of the Journal of...ns of the herpes virus -- HSV-1, the strain that c...
...ials reported that the number of HIV infected chil... The Kazakh health minister and a regional govern...ing the detection of 61 cases out of which 4 have ...isease. The Kazakh Prosecutor General's office ha...
...icacy of food labels and test if it meets the inte...sity for Health Services //embarked on a survey in...aled, despite the enduring habit of reading food-l...nsumers did not assimilate the information. The po...
...ists at the University of California in Los Angele...f the information to patients for them to take the...n that there is actually a lack of communication b...d the lead author Derjung M. Tarn. The study is pu...
Other Medicine News:Health News:Herpes Infects Cornea, Evades Immune Cells 2Health News:Doctors to give complete information on prescriptions to patients 2Health News:Doctors to give complete information on prescriptions to patients 3DSL's unique DHEA-S-7kits feature a highly specific antiserum targeted against the C-7 position of the DHEA-S molecule, with no cross-reactivity with DHEA. DSL's DHEA-S Saliva RIA has been optimized
Inquire
Rapid latex slide agglutination assay for the qualitative and semi-quantitative determination of Rheumatoid Factors in human serum.
Equipped with the SYNCHRON CX4 PRO, which includes many of today's most advanced and automated technologies, your laboratory can improve its specialty testing process dramatically. The SYNCHRON CX4 P
Medicine Products:(Date:11/28/2008)...ll/ -- Eli Lilly and Company,(NYSE: LLY ) has w...DA) from,the U.S. Food and Drug Administration (F...gement of chronic pain. Lilly plans to resubmit th...ata from a recently completed positive study,in c...he decision does not affect duloxetine,s FDA-appro...
(Date:11/26/2008)... and intelligent clinical applications take workfl... , CHICAGO, Ill., Nov. 26 /PRNewswire-FirstC...ealthcare ) highlights the ACUSON S2000(TM) Autom... first multi-use, automated volume breast ultrasou...ual Meeting of the Radiological Society of North A...
(Date:11/25/2008)...wswire/ -- Kleinert Kutz and University of Louisv...transplant on Messina, New York resident, Jan "Eri...Care Center on Monday, November 24. The innovativ...ortly after 9 p.m. in a record nine hours. , ,...20081125/DC48555-a ) , (Photo: http://www.new...
(Date:11/25/2008)...ewswire-FirstCall/ -- Poniard,Pharmaceuticals, In...focused on,innovative oncology therapies, announc...rnatives for its preclinical research programs in ... on the clinical development of picoplatin,its l...commercialization of,picoplatin in the treatment ...
Breaking Medicine Technology:Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3Kidney function discovery sheds light on genetic complexity of disease 6056 1Kidney function discovery sheds light on genetic complexity of disease 6056 2MySignatureBook Certified Compliant With SAFE BioPharma Digital Standard 28TM 29 9382 1MySignatureBook Certified Compliant With SAFE BioPharma Digital Standard 28TM 29 9382 2MySignatureBook Certified Compliant With SAFE BioPharma Digital Standard 28TM 29 9382 3The SCOOTER Store Gives Power Wheelchair to Good Samaritan Critically Injured Trying to Save Others 30689 1The SCOOTER Store Gives Power Wheelchair to Good Samaritan Critically Injured Trying to Save Others 30689 2The SCOOTER Store Gives Power Wheelchair to Good Samaritan Critically Injured Trying to Save Others 30689 3Resverlogix Board of Directors Update 9378 1Resverlogix Board of Directors Update 9378 2[0] Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain[0] Siemens Introduces New Standard of Care for Breast Ultrasound[1] Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center[0] Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin
...2007 /PRNewswire-FirstCall/ --,Alpharma Inc. , a l...ough its Pharmaceuticals Division, this week prese...f its investigational,abuse-deterrent, extended-re... of the American Pain Society in Washington, D.C.,...of this,extended-release morphine sulfate plus seq...
...t="_blank" href=,"http://www.omxgroup.com/">www.om... DMYDY) , , STOCKHOLM, Sweden, May 3, 2007 &ndas... at the Sweden-Seattle Diabetes Conference,this pa...cipal,Investigator in Diamyd’s previously re...s, presented potentially scientifically,ground-bre...
Other Medicine Technology:Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 2Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 3Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 4Revolutionary Immunologic Data Explains Function of Diamyd Diabetes,Vaccine 2Revolutionary Immunologic Data Explains Function of Diamyd Diabetes,Vaccine 3Revolutionary Immunologic Data Explains Function of Diamyd Diabetes,Vaccine 4Revolutionary Immunologic Data Explains Function of Diamyd Diabetes,Vaccine 5| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |